Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work.

Most opposition to the federal WISeR program focuses on delay in care. Not addressed is the economic and compassionate necessity of WISeR, a physician writes.

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up questions. In a first, the federal government is allowing ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter.

Original Medicare covers opioid treatment programs (OTPs) for opioid use disorder (OUD) from Part B. The program must be government-certified and accredited by an independent, government-approved accrediting body. Opioid use disorder (OUD) is a severe ...

The Centers for Medicare and Medicaid Services’ Medicare GLP-1 Bridge program will decrease certain GLP-1 costs, which local health care leaders said will make the weight-loss drugs more affordable an